I. Exploration-biologique and .. , 46 III.1. Tests globaux d'exploration de l'hémostase primaire, p.46

V. Le and . Le, principal acteur de l'adhésion plaquettaire. Il s'agit d'une glycoprotéine synthétisée à la fois par les cellules endothéliales (70%) et par les mégacaryocytes (30%)

. La, altère la fonction plaquettaire qu'à des hautes concentrations (1mg/ml), dépassant les doses usuelles thérapeutiques. D'après une étude (Lossasso C, 1995) in vitro, l'agrégation plaquettaire induite par l'ADP et le collagène est diminuée à ces concentrations

. La-péfloxacine-n, altère pas la fonction plaquettaire En effet, à des doses thérapeutiques, la péfloxacine n'a eu aucun impact sur l'agrégation plaquettaire induite par le collagène et l'ADP d'après une étude ex vivo, Cazzola M, 1995.

. La-ristocétine-n, est plus utilisée à l'heure actuelle comme antibiotique, mais elle est utilisée en agrégométrie pour le diagnostic de la maladie de Willebrand

L. Téicoplanine, provoque in vitro une agrégation plaquettaire spontanée à une concentration élevée (10mg/ml) mais inhibe l'agrégation plaquettaire induite par différents agonistes (ADP, collagène, ristocétine) La concentration de 10 mg/ml est 100 fois supérieure à la concentration usuelle (100 ?g/ml), 1987.

L. Effets-de-la-vitamine and E. , Les différentes études réalisées à partir de l'alpha tocophérols n'ont pas réussi à montrer de manière constante que celui-ci inhibait l'agrégation plaquettaire, Dereska NH, 2005.

. Une-Étude, ) a comparé les effets du tocophérol ? seul et de plusieurs tocophérols associés (?, ?, ?) Seule l'association de plusieurs tocophérols diminue l'agrégation plaquettaire induite par l'ADP. L'association de plusieurs tocophérols augmente également le libération de NO, 2003.

L. 'étude-in-vitro, ) a montré que l'agrégation plaquettaire n'était pas modifiée mais que la vitamine C pouvait réduire l'expression du CD40L, 2005.

V. Addonizio, . Jr, C. Fisher, J. Strauss, . Iii et al., Inhibition of human platelet function by verapamil, Thrombosis Research, vol.28, issue.4, pp.545-556, 1982.
DOI : 10.1016/0049-3848(82)90170-0

F. Akbiyik, D. Ray, K. Gettings, N. Blumberg, C. Francis et al., Human bone marrow megakaryocytes and platelets express PPAR??, and PPAR?? agonists blunt platelet release of CD40 ligand and thromboxanes, Blood, vol.104, issue.5, pp.1361-1368, 2004.
DOI : 10.1182/blood-2004-03-0926

T. Akimoto, I. Kusumi, K. Suzuki, T. Masui, and T. Koyama, Effects of valproate on serotonin-induced intracellular calcium mobilization in human platelets, J Psychiatry Neurosci, vol.32, pp.17-22, 2007.

F. Ali, P. Armstrong, A. Dhanji, A. Tucker, M. Paul-clark et al., Antiplatelet Actions of Statins and Fibrates Are Mediated by PPARs, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.29, issue.5, pp.706-711, 2009.
DOI : 10.1161/ATVBAHA.108.183160

J. Alvarez, D. Gluck, and I. Arnulf, Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: Effects of clomipramine and fluoxetine, Clinical Pharmacology & Therapeutics, vol.66, issue.6, pp.617-624, 1999.
DOI : 10.1053/cp.1999.v66.103402001

H. Aoki, T. Mizobe, S. Nozuchi, and N. Hiramatsu, In Vivo and In Vitro Studies of the Inhibitory Effect of Propofol on Human Platelet Aggregation, Anesthesiology, vol.88, issue.2, pp.362-370, 1998.
DOI : 10.1097/00000542-199802000-00015

M. Arruzazabala, V. Molina, R. Mas, L. Fernández, D. Carbajal et al., Antiplatelet effects of policosanol (20 and 40 mg/day) in healthy volunteers and dyslipidaemic patients, Clinical and Experimental Pharmacology and Physiology, vol.29, issue.10, pp.891-897, 2002.
DOI : 10.1016/S0011-393X(98)85030-3

A. Ataoglu and F. Canan, Mean Platelet Volume in Patients With Major Depression, Journal of Clinical Psychopharmacology, vol.29, issue.4, pp.368-371, 2009.
DOI : 10.1097/JCP.0b013e3181abdfd7

D. Atar, A. Malinin, A. Takserman, A. Pokov, L. Van-zyl et al., Escitalopram, but Not Its Major Metabolites, Exhibits Antiplatelet Activity in Humans, Journal of Clinical Psychopharmacology, vol.26, issue.2, pp.172-177, 2006.
DOI : 10.1097/01.jcp.0000204047.76286.6e

F. Avcu, A. Ural, T. Cetin, and O. Nevruz, Effects of bortezomib on platelet aggregation and ATP release in human platelets, in vitro, Thrombosis Research, vol.121, issue.4, pp.567-571, 2008.
DOI : 10.1016/j.thromres.2007.06.013

S. Axelsson, S. Hagg, A. Eriksson, T. Lindahl, and P. Whiss, IN VITRO EFFECTS OF ANTIPSYCHOTICS ON HUMAN PLATELET ADHESION AND AGGREGATION AND PLASMA COAGULATION, Clinical and Experimental Pharmacology and Physiology, vol.169, issue.8, pp.775-780, 2007.
DOI : 10.1056/NEJMoa022157

C. Balduini, P. Noris, S. Belletti, P. Spedini, and G. Gamba, In vitro and in vivo effects of desmopressin on platelet function, Haematologica, vol.84, pp.891-986, 1999.

M. Platelet, during treatment with pegylated interferon-alfa in melanoma patients, Progress Neuro-Psychopharmacol Biol Psychiatry, vol.29, pp.109-114, 2005.

P. Baum, P. Sullam, C. Stoddart, and J. Mccune, Abacavir increases platelet reactivity via competitive inhibition of soluble guanylyl cyclase, AIDS, vol.25, issue.18, pp.2243-2248, 2011.
DOI : 10.1097/QAD.0b013e32834d3cc3

G. Bauriedel, D. Skowasch, M. Schneider, R. Andrie, A. Jabs et al., Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: A pilot study with whole-blood aggregometry, American Heart Journal, vol.145, issue.2, pp.343-348, 2003.
DOI : 10.1067/mhj.2003.22

D. Basila and C. Yuan, Effects of dietary supplements on coagulation and platelet function, Thrombosis Research, vol.117, issue.1-2, pp.49-53, 2005.
DOI : 10.1016/j.thromres.2005.04.017

I. Beales, M. Clemons, and W. Kong, Misoprostol-associated platelet aggregation dysfunction and increased gastrointestinal blood loss, European Journal of Gastroenterology & Hepatology, vol.9, issue.1, pp.91-92, 1997.
DOI : 10.1097/00042737-199701000-00021

S. Belluci, Physiologie de l'hémostase primaire, Hématologie, pp.13-019, 2002.

R. Berntsen, T. Simonsen, G. Sager, and H. Olsen, Therapeutic lidocaine concentrations have no effect on blood platelet function and plasma catecholamine levels, European Journal of Clinical Pharmacology, vol.42, issue.1, pp.109-111, 1992.
DOI : 10.1161/01.RES.58.1.172

Y. Bismuth-evenzal, Y. Gonopolsky, D. Gurwitz, I. Iancu, A. Weizman et al., Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs, Journal of Affective Disorders, vol.136, issue.1-2, pp.99-103, 2012.
DOI : 10.1016/j.jad.2011.08.013

A. Blann, S. Nadar, and G. Lip, Pharmacological Modulation of Platelet Function in Hypertension, Hypertension, vol.42, issue.1
DOI : 10.1161/01.HYP.0000077901.84467.E1

M. Bouaouina and L. Halbwachs-mecarelli, Activation des intégrines et adhérence des leucocytes et des plaquettes, Hématol, vol.12, pp.21-33, 2006.

M. Cazzola, G. Santangelo, M. Angrisani, A. Vinciguerra, C. Contaldi et al., Evaluation of the effects of pefloxacin on platelet aggregation in vitro and ex vivo in patients suffering from chronic bronchitis

T. Celik, U. Yuksel, A. Iyisooy, H. Kursaklioglu, O. Ozcan et al., Effects of nebivolol on platelet activation in hypertensive patients: A comparative study with metoprolol, International Journal of Cardiology, vol.116, issue.2, pp.206-211, 2007.
DOI : 10.1016/j.ijcard.2006.03.046

T. Chakroun and E. I. Agrégométrie, Encycl Méd Chir (Editions Médicales Scientifiques, Paris, tous droits réservés), Biologie Médicale, pp.90-60, 2005.

Y. Chang, J. Lee, W. Chen, D. Chou, S. Huang et al., A novel role for tamoxifen in the inhibition of human platelets, Translational Research, vol.157, issue.2, pp.81-91, 2011.
DOI : 10.1016/j.trsl.2010.10.004

N. Chronos, A. Goodall, D. Wilson, U. Sigwart, and N. Buller, Profound platelet degranulation is an important side effect of some types of contrast media used in interventional cardiology, Circulation, vol.88, issue.5, pp.2035-2044, 1993.
DOI : 10.1161/01.CIR.88.5.2035

E. Coban and B. Afacan, The effect of rosuvastatin treatment on the mean platelet volume in patients with uncontrolled primary dyslipidemia with hypolipidemic diet treatment, Platelets, vol.6, issue.2, pp.111-114, 2008.
DOI : 10.1088/0143-0815/6/3/003

H. Dai, J. Chen, Q. Tao, J. Zhu, F. Zhang et al., Effects of diltiazem on platelet activation and cytosolic calcium during percutaneous transluminal coronary angioplasty, Postgraduate Medical Journal, vol.79, issue.935, pp.522-526, 2003.
DOI : 10.1136/pmj.79.935.522

D. Clerck, F. Somers, Y. Mannaert, E. Greenspan, A. Eerdekens et al., In vitro effects of risperidone and 9-hydroxy-risperidone on human platelet function, plasma coagulation, and fibrinolysis, Clinical Therapeutics, vol.26, issue.8, pp.161-1273, 2004.
DOI : 10.1016/S0149-2918(04)80097-3

D. Agli, M. Maschi, O. Galli, G. Fagnani, R. Cero et al., Inhibition of platelet aggregation by olive oil phenols via cAMP-phosphodiesterase, Br J Nutrition, vol.99, pp.945-951, 2008.

R. Demirtunc, D. Duman, and M. Basar, Effects of Doxazosin and Amlodipine on Mean Platelet Volume and Serum??Serotonin Level in Patients with??Metabolic Syndrome, Clinical Drug Investigation, vol.41, issue.1, pp.435-441, 2007.
DOI : 10.1042/cs0870253

N. Dereska, E. Mclemore, D. Tessier, D. Bash, and C. Brophy, Short-term, Moderate Dosage Vitamin E Supplementation May Have No Effect on Platelet Aggregation, Coagulation Profile, and Bleeding Time in Healthy Individuals, Journal of Surgical Research, vol.132, issue.1, pp.121-129, 2006.
DOI : 10.1016/j.jss.2005.09.031

B. De-roos, X. Zhang, R. Gutierrer, G. Wood, S. Rucklidge et al., Anti-platelet effects of olive oil extract: in vitro functional and proteomic studies, European Journal of Nutrition, vol.105, issue.7, pp.553-562, 2011.
DOI : 10.1182/blood-2004-02-0608

I. Dogan, E. Ovali, Z. Eti, A. Yayci, and F. Gogus, The in vitro effects of isoflurane, sevoflurane, and propofol on platelet aggregation, Anesth Analg, vol.88, pp.432-436, 1999.

J. Duchemin, F. Lion, B. Arnaud, M. Nicot, M. Blouch et al., Acquired thrombopathia related to montélukast therapy, Thromb haemost, vol.91, pp.1247-1248, 2004.

S. Dunkley and L. Gaudry, Thalidomide causes platelet activation, which can be abrogated by aspirin, Journal of Thrombosis and Haemostasis, vol.19, issue.6
DOI : 10.1111/j.1538-7836.2007.02542.x

I. Elalamy, Thrombopathies acquises et cong??nitales, EMC - H??matologie, vol.1, issue.1, pp.13-021, 2006.
DOI : 10.1016/S1155-1984(06)39843-3

I. Elalamy and . Pfa-100?, PFA-100??? (Dade Behring): un analyseur global de la qualit?? fonctionnelle de l'h??mostase primaire, Revue Francophone des Laboratoires, vol.2007, issue.393, pp.51-61, 2007.
DOI : 10.1016/S1773-035X(07)80265-6

M. El-sayed, Effects of alcohol ingestion post-exercise on platelet aggregation, Thrombosis Research, vol.105, issue.2, pp.147-151, 2002.
DOI : 10.1016/S0049-3848(02)00008-7

I. Erlund, R. Koli, G. Alfthan, J. Marniemi, P. Puukka et al., Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol, The American Journal of Clinical Nutrition, vol.4, issue.2, pp.323-331, 2008.
DOI : 10.1111/j.1538-7836.2006.01771.x

P. Fagerstam, A. Ostberg, A. Eriksson, S. Fransson, and P. Whiss, Similar inhibition of platelet adhesion, P-selectin expression and plasma coagulation by ioversol, iodixanol and ioxaglate, The British Journal of Radiology, vol.83, issue.989, pp.401-410, 2012.
DOI : 10.1016/S1076-6332(03)80456-7

M. Falciani, B. Rinaldi, D. Agostino, B. Mazzeo, F. Rossi et al., Effects of Nebivolol on Human Platelet Aggregation, Journal of Cardiovascular Pharmacology, vol.38, issue.6, pp.922-929, 2001.
DOI : 10.1097/00005344-200112000-00014

A. Flammer, F. Hermann, I. Sudano, L. Spieker, M. Hermann et al., Dark Chocolate Improves Coronary Vasomotion and Reduces Platelet Reactivity, Circulation, vol.116, issue.21, pp.2376-2382, 2007.
DOI : 10.1161/CIRCULATIONAHA.107.713867

URL : http://circ.ahajournals.org/content/circulationaha/116/21/2376.full.pdf

A. Flock, A. Zobel, G. Bauriedel, I. Tuleta, C. Hammerstingl et al., Antiplatelet effects of antidepressant treatment: A randomized comparison between escitalopram and nortriptyline, Thrombosis Research, vol.126, issue.2, pp.83-87, 2010.
DOI : 10.1016/j.thromres.2010.04.020

O. Fourcade, M. Simon, L. Litt, K. Samii, and H. Chap, Propofol Inhibits Human Platelet Aggregation Induced by Proinflammatory Lipid Mediators, Anesthesia & Analgesia, vol.99, pp.393-398, 2004.
DOI : 10.1213/01.ANE.0000123491.08697.CA

A. Gasparyan, A. Sandoo, A. Stavropoulos-kalinoglou, and G. Kitas, Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-alpha therapy, Rheumatology International, vol.19, issue.8, pp.1125-1129, 2010.
DOI : 10.1007/s00296-009-1345-1

URL : https://hal.archives-ouvertes.fr/hal-00568325

J. Gebalska, R. Wolk, and L. Ceremuznski, Isosorbide dinitrate inhibits platelet adhesion and aggregation in nonthrombolyzed patients with acute myocardial infarction, Clinical Cardiology, vol.59, issue.11, pp.837-841, 2000.
DOI : 10.3181/00379727-132-34362

K. Gibson, T. Winterburn, F. Barrett, S. Sharma, S. Macrury et al., Therapeutic potential of N-acetylcysteine as an antiplatelet agent in patiens with type-2 diabetes, Cardiovascular Diabetol, vol.10, pp.1-8, 2011.

G. Gleerup, J. Petersen, and J. Mehlsen, Effect of Spirapril and Hydrochlorothiazide on Platelet Function and Euglobulin Clot Lysis Time in Patients with Mild Hypertension, Angiology, vol.57, issue.10, pp.951-956, 1996.
DOI : 10.1056/NEJM198512193132501

G. Gleerup and K. Winther, Decreased Fibrinolytic Activity and Increased Platelet Function in Hypertension, American Journal of Hypertension, vol.4, issue.2_Pt_2, pp.168-171, 1991.
DOI : 10.1093/ajh/4.2.168S

E. Gomez-gil, C. Gasto, and M. Carretero, Decrease of the platelet 5-HT2A receptor function by long-term imipramine treatment in endogenous depression, Human Psychopharmacology: Clinical and Experimental, vol.19, issue.4, pp.251-258, 2004.
DOI : 10.1002/hup.583

X. Gu and G. Herrera, Thrombotic microangiopathy in cocaine abuse-associated malignant hypertension

B. Guillet, P. Jego, and P. Gueret, Les nouvelles méthodes diagnostiques en hémostase, Spectre Biol, vol.167, pp.34-39, 2008.

K. Grotemeyer, The platelet-reactivity-test ??? A useful ???by-product??? of the blood-sampling procedure?, Thrombosis Research, vol.61, issue.4
DOI : 10.1016/0049-3848(91)90656-H

H. Gutman, J. Schachter, E. Stopel, R. Gutman, and J. Lahav, Impaired platelet aggregation in melanoma patients treated with interferon-?-2b adjuvant therapy, Cancer, vol.74, issue.3, pp.780-785, 2002.
DOI : 10.1002/(SICI)1097-0142(19990115)85:2<257::AID-CNCR1>3.0.CO;2-2

URL : http://onlinelibrary.wiley.com/doi/10.1002/cncr.10261/pdf

M. Hacquard, S. Richard, J. Lacour, T. Lecompte, and H. Vespignani, Levetiracetam-induced platelet dysfunction, Epilepsy Research, vol.86, issue.1, pp.94-96, 2009.
DOI : 10.1016/j.eplepsyres.2009.04.003

J. Halcox, K. Nour, G. Zalos, R. Mincemoyer, M. Waclawiw et al., The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia, Journal of the American College of Cardiology, vol.40, issue.7, pp.1232-1240, 2002.
DOI : 10.1016/S0735-1097(02)02139-3

D. Halperin and G. Reber, Influence of antidepressants on hemostasis, Dialogues Clinical Neuroscience, vol.9, pp.47-59, 2007.

P. Harrison, I. Mackie, A. Mumford, C. Briggs, R. Liesner et al., Guidelines for the laboratory investigation of heritable disorders of platelet function, British Journal of Haematology, vol.123, issue.Suppl. 2, pp.30-44, 2011.
DOI : 10.1309/Y9EC63RW3XG1V313

S. Heptinstall, A. White, N. Edwards, J. Pascoe, H. Sanderson et al., Differential effects of three radiographic contrast media on platelet aggregation and degranulation: implications for clinical practice?, British Journal of Haematology, vol.193, issue.399, pp.1023-1030, 1998.
DOI : 10.1148/radiology.193.3.7972831

J. Guerrero-pajuelo and B. Pacheco, Effects of amlodipine and enalapril on platelet function in patients with mild to moderate hypertension, Int J Clin Pharmacol Ther, vol.37, pp.323-331, 1999.

H. Hirakata, K. Nakamura, S. Sai, H. Okuda, Y. Hatano et al., Platelet aggregation is impaired during anaesthesia with sevoflurane but not with isoflurane, Canadian Journal of Anaesthesia, vol.8, issue.11, pp.1157-1161, 1997.
DOI : 10.1253/jcj.51.495

H. Hirakata, K. Nakamura, B. Yokubol, H. Toda, Y. Hatano et al., Propofol Has Both Enhancing and Suppressing Effects on Human Platelet Aggregation In Vitro, Anesthesiology, vol.91, issue.5, pp.1361-1369, 1999.
DOI : 10.1097/00000542-199911000-00028

B. Hiyasat, D. Sabha, K. Grotzinger, J. Kempfert, J. Rauwald et al., Antiplatelet Activity of <i>Allium ursinum</i> and <i>Allium sativum</i>, Pharmacology, vol.83, issue.4, pp.197-204, 2009.
DOI : 10.1159/000196811

M. Horellou, J. Conard, and M. Samama, Allongement du temps de saignement, AKOS Encyclopédie Pratique de Médecine, pp.1-1170, 2001.
DOI : 10.1016/S1634-6939(06)75176-6

G. Huang, C. Li, P. Hsu, C. Tsai, T. Lin et al., Sevoflurane Anesthesia Attenuates Adenosine Diphosphate-Induced P-Selectin Expression and Platelet-Leukocyte Conjugate Formation, Anesthesia & Analgesia, vol.99, issue.4, pp.1121-1126, 2004.
DOI : 10.1213/01.ANE.0000130620.79832.23

URL : http://pdfs.journals.lww.com/anesthesia-analgesia/2004/10000/Sevoflurane_Anesthesia_Attenuates_Adenosine.30.pdf?token=method|ExpireAbsolute;source|Journals;ttl|1504238658166;payload|mY8D3u1TCCsNvP5E421JYK6N6XICDamxByyYpaNzk7FKjTaa1Yz22MivkHZqjGP4kdS2v0J76WGAnHACH69s21Csk0OpQi3YbjEMdSoz2UhVybFqQxA7lKwSUlA502zQZr96TQRwhVlocEp/sJ586aVbcBFlltKNKo+tbuMfL73hiPqJliudqs17cHeLcLbV/CqjlP3IO0jGHlHQtJWcICDdAyGJMnpi6RlbEJaRheGeh5z5uvqz3FLHgPKVXJzdOHIHwDOSay4QvwGGy628k9ikDRBds9dLmyp9ZsToF6zwp09FVW4BBlMKtg3znxs1;hash|M+s0R3B97gS0FQKjDlyvPw==

G. Huang, T. Lin, J. Wang, C. Ku, S. Ho et al., Lidocaine Priming Reduces ADP-induced P-selectin Expression and Platelet???Leukocyte Aggregation, Acta Anaesthesiologica Taiwanica, vol.47, issue.2, pp.56-61, 2009.
DOI : 10.1016/S1875-4597(09)60025-4

URL : https://doi.org/10.1016/s1875-4597(09)60025-4

B. Hugel, O. Morel, J. Freyssinet, and F. Toti, Microparticules procoagulantes en pathologie cardiovasculaire, MT Cardio, vol.2, pp.78-87, 2006.

M. Jandrot-perrus, M. Gratacap, T. Lhermusier, P. Sié, and B. Payrastre, Nouvelles molécules ciblées et modulation des fonctions laquettaires : anticpier, démontrer, gérer, utiliser, Hematol, vol.16, pp.345-354, 2010.

M. Jandrot-perrus and P. Nurden, Des fonctions plaquettaires aux implications th??rapeutiques, La Revue de M??decine Interne, vol.31, pp.319-323, 2010.
DOI : 10.1016/j.revmed.2010.09.020

F. Jobin and . L-'hémostase, 3 ème éd. Paris : Maloine, 1999.

F. Jobin and . Thrombose, Paris : Maloine, 1995.

C. Jones, F. Pasanisi, H. Elliott, and J. Reid, Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies., British Journal of Clinical Pharmacology, vol.100, issue.Suppl. I, pp.191-196, 1985.
DOI : 10.1016/0014-2999(84)90001-3

F. Jung, S. Spitzer, and G. Pindur, Effect of an Ionic Compared to a Non-Ionic X-Ray Contrast Agent on Platelets and Coagulation during Diagnostic Cardiac Catheterisation, Pathophysiology of Haemostasis and Thrombosis, vol.32, issue.3, pp.121-126, 2002.
DOI : 10.1159/000065213

L. Kalinowski, T. Matys, E. Chabielska, W. Buczko, and T. Malinski, Angiotensin II AT1 Receptor Antagonists Inhibit Platelet Adhesion and Aggregation by Nitric Oxide Release, Hypertension, vol.40, issue.4, pp.521-527, 2002.
DOI : 10.1161/01.HYP.0000034745.98129.EC

URL : http://hyper.ahajournals.org/content/hypertensionaha/40/4/521.full.pdf

K. Kaptan, K. Erinc, A. Ifran, V. Yildirim, M. Uzun et al., Levosimendan has an inhibitory effect on platelet function, American Journal of Hematology, vol.20, issue.1, pp.46-49, 2008.
DOI : 10.1161/01.ATV.20.2.285

URL : http://onlinelibrary.wiley.com/doi/10.1002/ajh.20999/pdf

B. Klein, D. Bach, I. Rehfeld, E. Kirchhoff, T. Hohlfeld et al., Influence of Mycophenolic Acid and FK???506 on Human Platelet Activation in vitro, Kidney and Blood Pressure Research, vol.23, issue.2, pp.119-124, 2000.
DOI : 10.1159/000025963

M. Kikura, T. Kazama, T. Ikeda, and S. Sato, Disaggregatory effects of prostaglandin E1, amrinone and milrinone on platelet aggregation in human whole blood, Platelets, vol.11, pp.446-458, 2000.

C. Knight, M. Panesar, D. Wilson, N. Chronos, D. Patel et al., Different Effects of Calcium Antagonists, Nitrates, and ??-Blockers on Platelet Function: Possible Importance for the Treatment of Unstable Angina, Circulation, vol.95, issue.1, pp.125-132, 1997.
DOI : 10.1161/01.CIR.95.1.125

J. Kort, S. Aslanyan, J. Scherer, J. Sabo, V. Kohlbrenner et al., Effects of Tipranavir, Darunavir, and Ritonavir on Platelet Function, Coagulation, and Fibrinolysis in Healthy Volunteers, Current HIV Research, vol.9, issue.4, pp.237-246, 2011.
DOI : 10.2174/157016211796320306

A. Kribben, E. Fritschka, E. Sibold, M. Fassbender, M. Rothschild et al., Different effects of furosemide on alpha-adrenoceptors and on platelet aggregation in man, Klinische Wochenschrift, vol.88, issue.suppl 4, pp.624-627, 1988.
DOI : 10.1161/01.RES.53.5.630

S. Kumar, Valproate-induced bleeding: report of two cases and review of the literature, Indian Pediatrics, vol.42, pp.833-844, 2005.

V. Latger-cannard, D. Sommelet, B. Guerci, P. Tréchot, and T. Lecompte, Platelet Gigantism Associated With Cholestyramine Therapy, Archives of Internal Medicine, vol.161, issue.21, pp.2619-2620, 2001.
DOI : 10.1001/archinte.161.21.2619-a

V. Latger-cannard, M. Hoarau, S. Salignac, D. Baumgart, P. Nurden et al., Mean platelet volume: comparison of three analysers towards standardization of platelet morphological phenotype, International Journal of Laboratory Hematology, vol.21, issue.3
DOI : 10.1046/j.1365-2257.1999.00200.x

M. Lecomte and P. Boivin, Filterability and pharmacology. Effects of methylxanthine derivatives on red cell phosphorylation, Scand J Clin Lab Invest, vol.156, pp.291-295, 1981.

C. Leong, A. Aini-ardena, S. Cheong, and N. Norris, Effect of pyridostigmine on human platelet aggregation, Malays J Pathol, vol.31, pp.45-52, 2009.

E. Lev, M. Arikan, M. Vaduganathan, C. Alviar, A. Tellez et al., Effect of caffeine on platelet inhibition by clopidogrel in healthy subjects and patients with coronary artery disease, American Heart Journal, vol.154, issue.4, pp.694-695, 2007.
DOI : 10.1016/j.ahj.2007.07.014

P. Levy, C. Yunis, J. Owen, B. Brosnihan, R. Smith et al., Inhibition of platelet aggregability by losartan in essential hypertension, The American Journal of Cardiology, vol.86, issue.11, pp.1188-1192, 2000.
DOI : 10.1016/S0002-9149(00)01200-5

P. Li, M. Fukuhara, D. Diz, C. Ferrario, and B. Brosnihan, Novel angiotensin II AT1 receptor antagonist irbesartan prevents thromboxane A2-induced vasoconstriction in canine coronary arteries and human platelet aggregation, J Pharmacol Experimental Therapeutics, vol.292, pp.238-246, 2000.

E. Liverani, . Banerjee, W. Roberts, K. Naseem, and M. Perretti, Prednisolone exerts exquisite inhibitory properties on platelet functions, Biochemical Pharmacology, vol.83, issue.10, pp.1364-1373, 2012.
DOI : 10.1016/j.bcp.2012.02.006

URL : https://doi.org/10.1016/j.bcp.2012.02.006

B. Lo, C. Kohrs, R. , M. Polanow-ska-grabow-ska, R. Gear et al., Local Anesthetic Actions on Thromboxane-Induced Platelet Aggregation, Anesthesia & Analgesia, vol.93, issue.5, pp.1240-1245, 2001.
DOI : 10.1097/00000539-200111000-00040

C. Losasso, A. Loffreda, M. Angrisani, C. Contaldi, M. Cazzola et al., Effects of Lomefloxacin and Sparfloxacin on Human Platelet Aggregation, Journal of Chemotherapy, vol.50, issue.2, pp.420-423, 1995.
DOI : 10.1016/0049-3848(84)90103-8

J. Malysko, J. Malysko, A. Takada, and M. Mysliwiec, Effects of immunosuppressive drugs on platelet aggregation in vitro, Ann Transplant, vol.7, pp.55-68, 2002.

J. Markovitz, J. Shuster, W. Chitwood, R. May, and L. Tolbert, Platelet Activation in Depression and Effects of Sertraline Treatment: An Open-Label Study, American Journal of Psychiatry, vol.157, issue.6, pp.1006-1008, 2000.
DOI : 10.1176/appi.ajp.157.6.1006

D. Mcglasson and G. Fritsma, Suppression of platelet aggregation cause by glucosamine supplement, pp.351-102

-. Meijer, W. Heerdink, E. Nolen, W. Herings, R. Leufkens et al., Association of Risk of Abnormal Bleeding With Degree of Serotonin Reuptake Inhibition by Antidepressants, Archives of Internal Medicine, vol.164, issue.21, pp.2367-2370, 2004.
DOI : 10.1001/archinte.164.21.2367

H. Mekhfi, E. Haouari, M. Legssyer, A. Bnouham, M. Aziz et al., Platelet anti-aggregant property of some Moroccan medicinal plants, Journal of Ethnopharmacology, vol.94, issue.2-3, pp.317-322, 2004.
DOI : 10.1016/j.jep.2004.06.005

S. Mohammad and R. Mason, Inhibition of Human Platelet-Collagen Adhesion Reaction by Amitriptyline and Imipramine, Experimental Biology and Medicine, vol.145, issue.3, pp.1106-1113, 1974.
DOI : 10.3181/00379727-145-37962

K. Mukamal, J. Massaro, K. Ault, M. Mittleman, P. Sutherland et al., Alcohol Consumption and Platelet Activation and Aggregation Among Women and Men: The Framingham Offspring Study, Alcoholism: Clinical & Experimental Research, vol.126, issue.10, pp.1906-1912, 2005.
DOI : 10.1111/j.1530-0277.2000.tb02021.x

C. Naranjo, U. Busto, and E. Sellers, A method for estimating the probability of adverse drug reactions, Clinical Pharmacology and Therapeutics, vol.30, issue.2
DOI : 10.1038/clpt.1981.154

F. Natella, M. Nardini, F. Belelli, P. Pignatelli, D. Santo et al., Effect of coffee drinking on platelets: inhibition of aggregation and phenols incorporation, British Journal of Nutrition, vol.326, issue.06, pp.1276-1282, 2008.
DOI : 10.1056/NEJM199201233260406

T. Niemi, E. Munsterhjelm, R. Poyhia, M. Hynninen, and M. Salmenpera, The effect of N-acetylcysteine on blood coagulation and platelet function in patients undergoing open repair of abdominal aortic aneurysm, Blood Coagulation & Fibrinolysis, vol.17, issue.1, pp.29-34, 2006.
DOI : 10.1097/01.mbc.0000195922.26950.89

R. Nosal, V. Jancinova, and E. Danihelova, Chloroquine: a multipotent inhibitor of human platelets in vitro

A. Nunez, J. Gomez, L. Zalba, M. Monton, A. Jimenez et al., Losartan inhibits in vitro platelet activation: comparison with candesartan and valsartan, Journal of the Renin-Angiotensin-Aldosterone System, vol.43, issue.355, pp.175-179, 2000.
DOI : 10.1093/eurheartj/15.suppl_D.79

N. Kennedy, L. Crosbie, M. Van-lieshou, J. Broom, D. Webb et al., Effects of antiplatelet components of tomato extract on platelet function in vitro and ex vivo: a time-course cannulation study in healthy humans, The American Journal of Clinical Nutrition, vol.12, issue.3, pp.570-579, 2006.
DOI : 10.1097/00004872-199408000-00012

H. Osamah, R. Mira, S. Sorina, K. Shlomo, and A. Michael, Reduced platelet aggregation after fluvastatin therapy is associated with altered platelet lipid composition and drug binding to the platelets, British Journal of Clinical Pharmacology, vol.44, issue.1, pp.77-84, 1997.
DOI : 10.1046/j.1365-2125.1997.00625.x

J. Ostrowska, M. Wojtukiewicz, E. Chabielska, W. Buczko, and H. Ostrowska, Proteasome inhibitor prevents experimental arterial thrombosis in renovascular hypertensive rats, Thrombosis and Haemostasis, vol.92, pp.171-177, 2004.
DOI : 10.1160/TH03-11-0707

I. Page, . Rl, and J. Bainbridge, Intractable Epistaxis Associated with Topiramate Administration, Annals of Pharmacotherapy, vol.9, issue.7-8, pp.1462-1465, 2006.
DOI : 10.1038/clpt.1981.154

J. Pasquet, Signalisation intracellulaire : la plaquette sanguine, un modèle d'étude [consulté le 20 Disponible à partir de : URL :<http://www.ufrsdv.u- bordeaux2.fr/siteIML

K. Pastakia, N. Brownson, D. Terle, and B. Poindexter, Amphotericin B induced abnormalities in human platelets, Molecular Pathology, vol.49, issue.5, pp.301-307, 1996.
DOI : 10.1136/mp.49.5.M301

S. Patel, I. Gojo, M. Tidwell, E. Sausville, and M. Baer, Subdural hematomas in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving imatinib mesylate in conjunction with systemic and intrathecal chemotherapy, Leukemia & Lymphoma, vol.52, issue.7, pp.1211-1214, 2011.
DOI : 10.1080/10428190310001615666

A. Pattison, N. Astley, C. Eason, and F. Bonner, A comparison of the effects of three positive inotropic agents (amrinone, milrinone and medorinone) on platelet aggregation in human whole blood, Thrombosis Research, vol.57, issue.6, pp.909-918, 1990.
DOI : 10.1016/0049-3848(90)90157-8

J. Pechan and A. Okrucka, Diltiazem inhibits the spontaneous platelet aggregation in essential hypertension, Cardiology, vol.79, pp.116-119, 1991.

M. Perusquia, J. Espinoza, and A. Pena, Mifepristone (RU 486) induces vasodilation and inhibits platelet aggregation: nongenomic and genomic action to cause hemorrhage, Contraception, vol.84, issue.2, pp.169-177, 2011.
DOI : 10.1016/j.contraception.2010.12.009

M. Petrikova, V. Jancinova, R. Nosal, M. Majekova, and V. Fabryova, Carvedilol-a beta-blocker with considerable antiaggregatory effect on human blood platelets, Bratisl Lek Listy, vol.106, pp.20-25, 2005.

M. Silvestri, A. Ghiselli, and F. Violi, Red and white wine differently affect collagen-induced platelet aggregation, Pathophysiol Haemost Thromb, vol.32, pp.356-358, 2002.

P. Pignatelli, V. Sanguigni, S. Paola, L. Cocco, E. Lenti et al., Vitamin C inhibits platelet expression of CD40 ligand, Free Radical Biology and Medicine, vol.38, issue.12, pp.1662-1666, 2005.
DOI : 10.1016/j.freeradbiomed.2005.02.032

H. Pilmore and R. Walker, Prolonged bleeding time during ciprofloxacin therapy, Journal of Clinical Pharmacy and Therapeutics, vol.91, issue.6, pp.45-46, 1995.
DOI : 10.1016/0002-9343(89)90033-8

D. Pinthong, P. Songsermsakul, P. Rattanachamnong, and D. Kendall, The effects of imidazoline agents on the aggregation of human platelets, Journal of Pharmacy and Pharmacology, vol.78, issue.2, pp.213-220, 2004.
DOI : 10.1111/j.1474-8673.1991.tb00258.x

K. Plaschke, C. Rosenhagen, S. Wagner, S. Hofer, and J. Kopitz, The inhibitory in-vitro effect of high-dose levosimendan on platelet function may be mediated through its action as a phosphodiesterase inhibitor, Coronary Artery Disease, vol.23, issue.3
DOI : 10.1097/MCA.0b013e32835167cc

L. Puccettia, F. Santilli, A. Pasquia, S. Lattanziob, R. Liani et al., Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia, Atherosclerosis, vol.214, issue.1, pp.122-128, 2011.
DOI : 10.1016/j.atherosclerosis.2010.10.006

A. Punda, S. Poliae, Z. Rumboldt, J. Bagatin, V. Markoviae et al., Effects of atenolol and propranolol on platelet aggregation in moderate essential hypertension: randomized crossover trial, Croat Med J, vol.46, pp.219-224, 2005.

A. Quintas-cardama, X. Han, H. Kantarjian, and J. Cortes, Tyrosine kinase inhibitor-induced platelet dysfunction in patients with chronic myeloid leukemia, Blood, vol.114, issue.2, pp.261-263, 2009.
DOI : 10.1182/blood-2008-09-180604

D. Rein, T. Paglieroni, T. Wun, D. Pearson, H. Schmitz et al., Cocoa inhibits platelet activation and function, The American Journal of Clinical Nutrition, vol.177, issue.1, pp.30-35, 2000.
DOI : 10.1006/cimm.1997.1109

URL : https://academic.oup.com/ajcn/article-pdf/72/1/30/23960557/30.pdf

T. Revel and K. Doghmi, Physiologie de l'hémostase. Encycl Méd Chir (Editions Médicales Scientifiques, Paris, tous droits réservés), Dentisterie, p.10, 2004.

E. Rossi, W. Levin, and G. Louis, Inhibition of Primary ADP-Induced Platelet Aggregation in Normal Subjects after Administration of Nitrofurantoin (Furadantin), Journal of Clinical Investigation, vol.52, issue.10, pp.2457-2467, 1973.
DOI : 10.1172/JCI107437

G. Sahin, O. Akay, C. Bal, A. Yalcin, and Z. Gulbas, The effect of calcineurine inhibitors on endothelial and platelet function in renal transplant patients, Clinical Nephrol, vol.76, pp.218-225, 2011.

A. Sarma, I. Horne, and . Mk, Venlafaxine-induced ecchymoses and impaired platelet aggregation, European Journal of Haematology, vol.23, issue.6, pp.77-533, 2006.
DOI : 10.1038/218137a0

A. Schedel, S. Thornton, H. Kluter, and P. Bugert, The Effect of Psychoactive Drugs on in vitro Platelet Function, Transfusion Medicine and Hemotherapy, vol.37, issue.5, pp.293-298, 2010.
DOI : 10.1159/000319841

. Sebahoun, Hématologie clinique et biologique. 2 ème éd. Rueil-Malmaison Cedex : Arnette Groupe Liaisons SA, 2005.

V. Serebruany, P. Gurbel, O. Connor, and C. , Platelet Inhibition by Sertraline and N-Desmethylsertraline: A Possible Missing Link Between Depression, Coronary Events, and Mortality Benefits of Selective Serotonin Reuptake Inhibitors, Pharmacological Research, vol.43, issue.5, pp.453-462, 2001.
DOI : 10.1006/phrs.2001.0817

J. Sheu, Y. Lee, L. Lee, H. Luk, and M. Yen, INHIBITORY MECHANISMS OF NALOXONE ON HUMAN PLATELETS, Clinical and Experimental Pharmacology and Physiology, vol.192, issue.7-8, pp.585-591, 1998.
DOI : 10.1007/978-1-4615-9442-0_10

W. Siess, R. Lorenz, P. Roth, and P. Weber, Effects of propranolol in vitro and in vivo on platelet function and thromboxane formation in normal volunteers, Agents and Actions, vol.13, pp.28-34, 1983.

D. Skowasch, A. Viktor, M. Schneider-schmitt, B. Luderitz, G. Nickenig et al., Differential antiplatelet effects of angiotensin converting enzyme inhibitors, Clinical Research in Cardiology, vol.19, issue.4, pp.212-216, 2006.
DOI : 10.1161/01.ATV.19.7.1791

A. Smith, J. Mcpherson, M. Taylor, A. Mason, S. Carney et al., Pro-haemorrhagic effects of calcium antagonists: a comparison of isradipine and atenolol on ex vivo platelet function in hypertensive subjects, Journal of Human Hypertension, vol.11, issue.12, pp.783-788, 1997.
DOI : 10.1038/sj.jhh.1000449

J. Czopf and K. Toth, Short term effect of low-dose atorvastatin on haemorrheological parameters, platelet aggregation and endothelial function in patients with cerebrovascular disease and hyperlipidaemia

C. Tham, M. Trew, and N. Brager, Abnormal clotting and production of factor VIII inhibitor in a patient treated with venlafaxine, Can J Psychiatry, vol.44, pp.923-924, 1999.

P. Tharmapathy, F. Selheim, K. Odegaard, A. Lund, and H. Holmsen, Venlafaxine Treatment Stimulates Blood Platelet Activity, Journal of Clinical Psychopharmacology, vol.20, issue.5, pp.589-590, 2000.
DOI : 10.1097/00004714-200010000-00023

H. Tinhg and F. Khasawneh, Glybenclamide: An antidiabetic with in vivo antithrombotic activity, European Journal of Pharmacology, vol.649, issue.1-3, pp.249-254, 2010.
DOI : 10.1016/j.ejphar.2010.09.009

H. Topf, M. Rauh, W. Rascher, and J. Dotsch, Endothelial cells influence the sodium nitroprusside mediated inhibition of platelet aggregation by an as yet unknown pathway, Thrombosis J 2012, vol.10, pp.6-10

M. Trzeciak and J. Bordet, Exploration de l'hémostase primaire, Encycl Méd Chir (Editions Scientifiques et Médicales Elsevier SAS, Paris, tous droits réservés), Hématologie, pp.13-019, 2002.

Y. Tseng, M. Chiang, T. Huang, K. Su, H. Lane et al., A selective serotonin reuptake inhibitor, citalopram, inhibits collagen-induced platelet aggregation and activation, Thrombosis Research, vol.126, issue.6, pp.517-523, 2010.
DOI : 10.1016/j.thromres.2010.09.017

H. Turkan, A. Suer, C. Beyan, and A. Yalcin, Propofol does not affect platelet aggregation, European Journal of Anaesthesiology, vol.13, issue.4, pp.408-409, 1996.
DOI : 10.1097/00003643-199607000-00019

M. Ueno, J. Ferreiro, S. Tomasello, A. Tello-montoliu, D. Capodanno et al., IMPACT OF PENTOXIFYLLINE ON PLATELET FUNCTION PROFILES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH CORONARY ARTERY DISEASE ON DUAL ANTIPLATELET THERAPY, Journal of the American College of Cardiology, vol.57, issue.14, pp.905-912, 2011.
DOI : 10.1016/S0735-1097(11)61920-7

A. Umar, F. Depont, A. Jacquet, S. Lignot, M. Segur et al., Effects of armagnac or vodka on platelet aggregation in healthy volunteers: a randomized controlled clinical trial, Thrombosis Research, vol.115, issue.1-2, pp.31-37, 2005.
DOI : 10.1016/j.thromres.2004.07.006

B. Van-zaane, E. Nur, A. Squizzato, V. Gerdes, H. Buller et al., Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors, Journal of Thrombosis and Haemostasis, vol.101, issue.11, pp.2483-2493, 2010.
DOI : 10.1001/archneur.62.2.249

I. Vasileiou, T. Xanthos, E. Koudouna, D. Perrea, C. Klonaris et al., Propofol: A review of its non-anaesthetic effects, European Journal of Pharmacology, vol.605, issue.1-3, pp.1-8, 2009.
DOI : 10.1016/j.ejphar.2009.01.007

D. Vital-durand, L. Jeune, and C. , Guide pratique des medicaments. 30e éd. Paris: Maloine, 2011.

H. Wallaschofski, M. Eigenthaler, M. Kiefer, M. Donne, and B. Hentschel, Hyperprolactinemia in Patients on Antipsychotic Drugs Causes ADP-Stimulated Platelet Activation That Might Explain the Increased Risk for Venous Thromboembolism: Pilot Study, Journal of Clinical Psychopharmacology, vol.23, issue.5, pp.479-483, 2003.
DOI : 10.1097/01.jcp.0000088914.24613.51

M. Wang, S. Giralt, K. Delasalle, B. Handy, and R. Alexanian, Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myeloma, Hematology, vol.90, issue.3, pp.235-239, 2007.
DOI : 10.1200/JCO.2005.04.242

M. Wesley, F. Mcgowan, R. Castro, S. Dissanayake, D. Zurakowski et al., The Effect of Milrinone on Platelet Activation as Determined by TEG?? Platelet Mapping???, Anesthesia & Analgesia, vol.108, issue.5, pp.1425-1429, 2009.
DOI : 10.1213/ane.0b013e3181981fbe

R. Woodman, C. Brown, and W. Lockette, Chlorthalidone Decreases Platelet Aggregation and Vascular Permeability and Promotes Angiogenesis, Hypertension, vol.56, issue.3, pp.463-470, 2010.
DOI : 10.1161/HYPERTENSIONAHA.110.154476

URL : http://hyper.ahajournals.org/content/hypertensionaha/56/3/463.full.pdf

X. Yang, J. Disa, and A. Rao, Effect of 1-desamino-8-D-arginine vasopressin (DDAVP) on human platelets, Thrombosis Research, vol.59, issue.5, pp.809-827, 1990.
DOI : 10.1016/0049-3848(90)90394-R

S. Yazici, M. Yazici, B. Erer, B. Erer, Y. Calik et al., The platelet indices in patients with rheumatoid arthritis: Mean platelet volume reflects disease activity, Platelets, vol.24, issue.2, pp.122-125, 2010.
DOI : 10.1186/ar1740

S. Yazici, M. Yazici, B. Erer, B. Erer, Y. Calik et al., therapy decreases the mean platelet volume and platelet mass, Platelets, vol.24, issue.2, pp.126-131, 2010.
DOI : 10.1002/art.511

B. Yokubol, H. Hirakata, K. Nakamura, S. Sai, H. Okuda et al., Anesthesia with sevoflurane, but not isoflurane, prolongs bleeding time in humans, Journal of Anesthesia, vol.13, issue.4, pp.193-196, 1999.
DOI : 10.1007/s005400050056

M. Zandecki and C. Binet, Société française d'hématologie. Hématologie. Abrégés. Issy-les-Moulineaux cedex, 2011.

M. Zangari, J. Guerrero, F. Cavallo, H. Prasad, D. Esseltine et al., Hemostatic effects of bortezomib treatment in patients with relapsed or refractory multiple myeloma, Haematologica, vol.93, issue.6, pp.953-954, 2008.
DOI : 10.3324/haematol.12522

M. Ziemen, P. Shah, and K. Breddin, Blutgerinnung unter Ciprofloxacin-Therapie, Infection, vol.7, issue.Suppl. 2, 1988.
DOI : 10.1007/BF01650512

. Sujet, Thrombopathies iatrogènes Président: Mme. Béatrice F AlYRE

L. Nancy and . Vu, 0':\ \c.. v 1'-\ lU